NCT04520308 An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis Status UNKNOWN Phase PHASE4
NCT04504955 CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness Status ENROLLING_BY_INVITATION Phase N/A
NCT04504279 Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04498403 A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis Status TERMINATED Phase PHASE3
NCT04490109 B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT04486742 Brief Cognitive Behavioral Therapy to Treat Itch Rumination "Itch CBT" in Eczema Status COMPLETED Phase NA
NCT04472546 Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis Status COMPLETED Phase NA
NCT04455906 Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism Status RECRUITING Phase N/A
NCT04444726 Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children. Status COMPLETED Phase NA
NCT04419584 Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children Status UNKNOWN Phase PHASE2/PHASE3
NCT04413942 Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis Status UNKNOWN Phase PHASE2
NCT04404075 Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use Status COMPLETED Phase N/A
NCT04398758 Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood Status UNKNOWN Phase PHASE3
NCT04392154 Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) Status COMPLETED Phase PHASE3
NCT04369846 A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients Status COMPLETED Phase PHASE1/PHASE2
NCT04360187 Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE3